# Beth E. Safirstein, M.D. – FDA Inspection, Jun 5, 2023

Source: https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/e0595441-9c6a-4d25-a3f5-654b001a98f8
Source feed: FDA_Inspections

> FDA inspection 1207723 of Beth E. Safirstein, M.D., June 05, 2023. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207723
- Company Name: Beth E. Safirstein, M.D.
- Inspection Date: 2023-06-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- [FDA Inspection 1098747 - 2019-08-06](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/56f744a3-0fd0-4e26-9963-5967f3affe43)
- [FDA Inspection 585191 - 2009-05-22](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/a2bc7837-fa31-463e-8d12-c0e5973192d5)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/richard-a-lyght/8d60b5c0-4acd-4abc-979a-fb4b3e82964d)

Company: https://www.keypedia.com/companies/beth-e-safirstein-md/9fdf7e95-e050-4f9d-bcd2-e00665e881c1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d